Implications of Myocardial Matrix Remodeling by Adipokines in Obesity-Related Heart Failure

Trends in Cardiovascular Medicine

Volumn 18, Issue 6, 2008, Pages 199-205

  Schram, Kristin ^a   Sweeney, Gary ^a  

^a YORK UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; COLLAGEN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENZYME INHIBITOR; ETANERCEPT; FOSINOPRIL; GELATINASE A; GELATINASE B; INFLIXIMAB; INTERSTITIAL COLLAGENASE; LEPTIN; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR; PD 116800; PD 166793; PG 116800; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

COLLAGEN SYNTHESIS; DRUG TARGETING; DRUG TREATMENT FAILURE; ENZYME INHIBITION; ENZYME REGULATION; EXTRACELLULAR MATRIX; HEART FAILURE; HEART INFARCTION; HEART MUSCLE; HEART MUSCLE CELL; HEART MUSCLE METABOLISM; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; HUMAN; MOLECULAR INTERACTION; MOLECULAR MECHANICS; NONHUMAN; OBESITY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; TISSUE REPAIR;

ADIPOKINES; ADIPONECTIN; COLLAGEN; CYTOKINES; EXTRACELLULAR MATRIX; HEART FAILURE; HUMANS; LEPTIN; MATRIX METALLOPROTEINASES; MYOCARDIUM; MYOCYTES, CARDIAC; OBESITY; VENTRICULAR REMODELING;

EID: 58649114508     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tcm.2008.10.001     Document Type: Review

References (41)

1. Abel E., Litwin S.E., and Sweeney G. Cardiac remodeling in obesity. Physiol Rev 88 (2008) 389-419
2. Anker S., and Coats A.J. How to RECOVER from RENAISSANCE? The significance of the results of RECOVER, RENAISSANCE, RENEWAL and ATTACH. Int J Cardiol 86 (2002) 123-130
3. Aubin M., Lajoie C., Clement R., et al. Female rats fed a high-fat diet were associated with vascular dysfunction and cardiac fibrosis in the absence of overt obesity and hyperlipidemia: therapeutic potential of resveratrol. J Pharmacol Exp Ther 325 (2008) 961-968
4. Barouch L., Berkowitz D.E., Harrison R.W., et al. Disruption of leptin signaling contributes to cardiac hypertrophy independently of body weight in mice. Circulation 108 (2003) 754-759
5. Bradham W., Bozkurt B., Gunasinghe H., et al. Tumor necrosis factor-α and myocardial remodeling in progression of heart failure: a current prospective. Cardiovasc Res 53 (2002) 822-830
6. Cao Q., Mak K.M., Ren C., and Lieber C.S. Leptin stimulates tissue inhibitor of metalloproteinase-1 in human hepatic stellate cells: respective roles of JAK/STAT and JAK-mediated H202-dependent MAPK pathways. J Biol Chem 279 (2004) 4292-4304
7. Chen T., Chen L., Hsieh M.S., et al. Evidence for a protective role for adiponectin in osteoarthritis. Biochem Biophys Res Comm 1762 (2006) 711-718
8. Cheng M., Hashmi S., Mao X., and Zeng Q.T. Relationships of adiponectin and matrix metalloproteinase-9 to tissue inhibitor of metalloproteinase-1 ratio with coronary plaque morphology in patients with acute coronary syndrome. Can J Cardiol 24 (2008) 385-390
9. Choudhury J., Mirshahi F., Murthy K.S., et al. Physiologic concentrations of leptin increase collagen production by non-immortalized human hepatic stellate cells. Metabolism 55 (2006) 1317-1322
10. Curtis J., Selter J.G., Wang Y., et al. The obesity paradox: body mass index and outcomes in patients with heart failure. Arch Intern Med 165 (2005) 55-61
11. Ding X., Saxena N., Lin S., et al. The roles of leptin and adiponectin: a novel paradigm in adipocytokine regulation of liver fibrosis and stellate cell biology. Am J Pathol 166 (2005) 1655-1669
12. Drimal J., Knezl V., Paulovicova E., and Drimal D. Enhanced early after-myocardial infarction concentration of TNF-α subsequently increased circulating and myocardial adrenomedullin in spontaneously hypertensive rats. Gen Physiol Biophys 27 (2008) 12-18
13. Ducharme A., Frantz S., Aikawa M., et al. Targeted deletion of MMP-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction. J Clin Invest 106 (2000) 55-62
14. Fang X., and Sweeney G. Mechanisms regulating energy metabolism by adiponectin in obesity and diabetes. Biochem Soc Trans 34 (2006) 798-801
15. Halaas J., Gajiwala K.S., Maffei M., et al. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269 (1995) 543-546
16. Hao G., Niu X.L., Gao D.F., et al. Agonists at PPAR-gamma suppress angiotensin II-induced production of plasminogen activator inhibitor-1 and extracellular matrix in rat cardiac fibroblasts. Br J Pharmacol 153 (2008) 1409-1419
17. Hudson M., Armstrong P.W., Ruzyllo W., et al. Effects of selective MMP inhibitor (PG-116800) to prevent ventricular remodeling after myocardial infarction: results of the PREMIER (Prevention of Myocardial Infarction Early Remodeling) trial. J Am Coll Cardiol 48 (2005) 15-20
18. Kassiri Z., Oudit G.Y., Sanchez O., et al. Combination of tumor necrosis factor-α ablation and matrix metalloproteinase inhibition prevents heart failure after pressure overload in tissue inhibitor of metalloproteinase-3 knock-out mice. Circ Res 97 (2005) 380-390
19. Kopelman P. Health risks associated with overweight and obesity. Obes Rev 8 (2007) 13-17
20. Kumada M., Kihara S., Ouchi N., et al. Adiponectin specifically increased TIMP-1 through interleukin-10 expression in human macrophages. Circulation 109 (2004) 2046-2049
21. Lago R., Gomez R., Otero M., et al. A new player in cartilage homeostasis: adiponectin induced nitric oxide synthase type II and pro-inflammatory cytokines in chondrocytes. Osteoarthritis Cartilage 16 (2008) 1101-1109
22. Lassila M., Fukami K., Jandeleit-Dahm K., et al. Plasminogen activator inhibitor-1 production is pathogenic in experimental murine diabetic renal disease. Diabetologia 50 (2007) 1315-1326
23. Lee M., Madani S., Sekula D., and Sweeney G. Leptin increases expression and activity of matrix metalloproteinases-2 and does not alter collagen production in rat glomerular mesangial cells. Endocrinol Res 31 (2005) 27-37
24. Lee S., Kim J.H., Park M.C., et al. Adiponectin mitigates the severity of arthritis in mice with collagen-induced arthritis. Scand J Rheumatol 37 (2008) 260-268
25. Li Y., Feng Y., Kadokami T., et al. Myocardial extracellular matrix remodeling in transgenic mice overexpressing tumor necrosis factor alpha can be modulated by anti-tumor necrosis factor alpha therapy. Proc Natl Acad Sci USA 97 (2000) 12746-12751
26. Lu L., Zhang Q., Pu L.J., et al. Dysregulation of matrix metalloproteinases and their tissue inhibitors is related to abnormality of left ventricular geometry and function in streptozotocin-induced diabetic minipigs. Int J Exp 89 (2008) 125-137
27. Madani S., De Girolamo S., Munoz D.M., et al. Direct effects of leptin on size and extracellular matrix components of human pediatric ventricular myocytes. Cardiovasc Res 69 (2006) 716-725
28. Mark A., Correia M.L., Rahmouni K., and Haynes W.G. Selective leptin resistance: a new concept in leptin physiology with cardiovascular implications. J Hypertens 20 (2002) 1245-1250
29. McElmurray J., Makherjee R., New R.B., et al. Angiotensin-converting enzyme and matrix metalloproteinase inhibition with developing heart failure: comparative effects on left ventricular function and geometry. J Pharmacol Exp Ther 291 (1999) 799-811
30. Moriwaki H., Stempien-Otero A., Kremen M., et al. Overexpression of urokinase by macrophages or deficiency of plasminogen activator inhibitor type 1 causes cardiac fibrosis in mice. Circ Res 95 (2004) 637-644
31. Niu L., Wang X., Li J., et al. Leptin stimulated alpha1(I) collagen expression in human hepatic stellate cells via the phosphatidylinositol 3-kinase/Akt signalling pathway. Liver Int 27 (2007) 1265-1272
32. Ohashi K., Iwatani H., Kihara S., et al. Exacerbation of albuminuria and renal fibrosis in subtotal renal ablation model of adiponectin-knockout mice. Arterioscler Thromb Vasc Biol 27 (2007) 1910-1917
33. Park H., Kwon H.M., Lim H.J., et al. Potential role of leptin in angiogenesis: leptin induces endothelial cell proliferation and expression of matrix metalloproteinases in vivo and in vitro. Exp Mol Med 33 (2001) 95-102
34. Park S., Cho Y.R., Kim H.J., et al. Unraveling the temporal pattern of diet-induced insulin resistance in individual organs and cardiac dysfunction in C57BL/6 mice. Diabetes 54 (2005) 3530-3540
35. Purdham D., Zou M.X., Rajapurohitam V., and Karmazyn M. Rat heart is a site of leptin production and action. Am J Physiol Heart Circ Physiol 287 (2004) H2877-H2884
36. Schram K., Wong M.M., Palanivel R., No E.K., et al. Increased expression and cell surface localization of MT1-MMP plays a role in stimulation of MMP-2 activity by leptin in neonatal rat cardiac myofibroblasts. J Mol Cell Cardiol 44 (2008) 874-881
37. Shibata R., Sato K., Pimentel D.R., et al. Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK and COX-2 dependent mechanisms. Nat Med 11 (2005) 1096-1103
38. Spinale F. Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function. Physiol Rev 87 (2007) 1285-1342
39. Thakker G., Frangogiannis N.G., Bujak M., et al. Effects of diet-induced obesity on inflammation and remodeling after myocardial infarction. Am J Physiol Heart Circ Physiol 291 (2006) H2504-H2514
40. Xia Q., Na T., Guo Y.M., et al. Improvement of chronic heart failure by dexamethasone is not associated with downregulation of leptin in rats. Acta Pharmacol Sin 28 (2007) 202-210
41. Yang R., and Barouch L. Leptin signaling and obesity: cardiovascular consequences. Cardiovasc Res 101 (2007) 545-559